Stock Value
Company Info
China Shineway Pharmaceutical Group Price Chart
China Shineway Pharmaceutical Group Stock Forecast 2023
In the last five quarters, China Shineway Pharmaceutical Group’s Price Target has risen from HK$5.77 to HK$11.63 - a 101.56% increase. Four analysts predict that China Shineway Pharmaceutical Group’s share price will fall in the coming year, reaching HK$11.34. This would represent a decrease of -2.49%.
Highest Price Target HK$16.61
Average Price Target HK$11.34
Lowest Price Target HK$11.09
China Shineway Pharmaceutical Group Stock Predictions 2025
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Jan 2025.
In January 2025, analysts believe the stock price will be HK$10.84. An increase of 14.32% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Feb 2025.
In February 2025, analysts believe the stock price will be HK$10.98. An increase of 15.85% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Mar 2025.
In March 2025, analysts believe the stock price will be HK$11.13. An increase of 17.38% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Apr 2025.
In April 2025, analysts believe the stock price will be HK$11.27. An increase of 18.91% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in May 2025.
In May 2025, analysts believe the stock price will be HK$11.42. An increase of 20.44% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Jun 2025.
In June 2025, analysts believe the stock price will be HK$11.56. An increase of 21.97% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Jul 2025.
In July 2025, analysts believe the stock price will be HK$11.71. An increase of 23.51% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Aug 2025.
In August 2025, analysts believe the stock price will be HK$11.85. An increase of 25.04% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Sep 2025.
In September 2025, analysts believe the stock price will be HK$12.00. An increase of 26.57% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Oct 2025.
In October 2025, analysts believe the stock price will be HK$12.14. An increase of 28.1% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Nov 2025.
In November 2025, analysts believe the stock price will be HK$12.29. An increase of 29.63% compared to the previous month's estimate.
Stock Forecast for the Price of an China Shineway Pharmaceutical Group Share in Dec 2025.
In December 2025, analysts believe the stock price will be HK$12.43. An increase of 31.16% compared to the previous month's estimate.
China Shineway Pharmaceutical Group Stock Prediction 2030
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Jan 2030.
In Jan 2030 analysts predict a share price of HK$11.60. An increase of 22.36% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Feb 2030.
In Feb 2030 analysts predict a share price of HK$11.77. An increase of 24.13% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Mar 2030.
In Mar 2030 analysts predict a share price of HK$11.93. An increase of 25.89% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Apr 2030.
In Apr 2030 analysts predict a share price of HK$12.10. An increase of 27.66% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in May 2030.
In May 2030 analysts predict a share price of HK$12.27. An increase of 29.42% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Jun 2030.
In Jun 2030 analysts predict a share price of HK$12.44. An increase of 31.18% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Jul 2030.
In Jul 2030 analysts predict a share price of HK$12.60. An increase of 32.95% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Aug 2030.
In Aug 2030 analysts predict a share price of HK$12.77. An increase of 34.71% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Sep 2030.
In Sep 2030 analysts predict a share price of HK$12.94. An increase of 36.48% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Oct 2030.
In Oct 2030 analysts predict a share price of HK$13.11. An increase of 38.24% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Nov 2030.
In Nov 2030 analysts predict a share price of HK$13.27. An increase of 40.01% compared to today's share price.
Stock Prediction for the Price of One China Shineway Pharmaceutical Group Share in Dec 2030.
In Dec 2030 analysts predict a share price of HK$13.44. An increase of 41.77% compared to today's share price.
China Shineway Pharmaceutical Group Analyst Ratings Frequently Asked Questions
Who are the analysts watching China Shineway Pharmaceutical Group Limited?
The following analysts have recently covered China Shineway Pharmaceutical Group:
Who are the sell-side analysts watching China Shineway Pharmaceutical Group Limited?
The following sell-side analysts have recently covered China Shineway Pharmaceutical Group:
